STOCK TITAN

ARIDIS PHARMACEUTICAL INC (ARDS) Total Assets by Year

ARDS

ARIDIS PHARMACEUTICAL INC closed fiscal year 2022 with $14.7M in total assets, $38.9M in total liabilities and -$24.2M in shareholder equity. This represents a decrease of 45.2% from the prior fiscal year. The table below carries 6 fiscal years, from 2017 to 2022, and the quarters ARIDIS PHARMACEUTICAL INC has filed alongside them.

FY2022 annual
Total Assets $14.7M
Total Liabilities $38.9M
Total Equity -$24.2M
YoY -45.2%
5Y CAGR -11.1%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2023, ended Sep 30, 2023 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ARDS Balance Sheet by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-K
Total Assets$14.7M-45.2%$26.8M+77.3%$15.1M-45.9%$28.0M-11.5%$31.6M+19.4%$26.5M
Total Liabilities$38.9M-2.5%$39.9M+67.7%$23.8M-2.2%$24.3M+359.3%$5.3M-94.1%$89.2M
Total Equity-$24.2M-84.8%-$13.1M-51.0%-$8.7M-338.8%$3.6M-86.2%$26.3M+141.9%-$62.8M

ARDS Balance Sheet by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2310-QQ2'2310-QQ1'2310-QQ4'2210-QQ3'2210-QQ2'2210-QQ1'2210-QQ4'2110-KQ3'2110-QQ2'2110-QQ1'2110-QQ4'2010-K
Total Assets$6.5M-46.1%$6.5M-61.2%$9.4M-60.4%$14.7M-45.2%$12.1M-53.5%$16.7M+46.5%$23.8M+35.6%$26.8M+77.3%$26.1M+115.5%$11.4M-37.1%$17.6M-20.2%$15.1M-45.9%
Total Liabilities$18.3M-61.8%$21.4M-49.1%$37.3M-14.1%$38.9M-2.5%$47.9M+58.5%$42.0M+68.8%$43.5M+66.4%$39.9M+67.7%$30.2M+29.2%$24.9M+2.8%$26.1M+7.1%$23.8M-2.2%
Total Equity-$11.8M+67.1%-$14.9M+46.6%-$27.9M-36.6%-$24.2M-84.8%-$35.8M-762.2%-$27.9M-107.1%-$20.4M-138.6%-$13.1M-51.0%-$4.2M+63.2%-$13.5M-122.0%-$8.6M-259.9%-$8.7M-338.8%

What total assets means

Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.

More ARIDIS PHARMACEUTICAL INC financials

Frequently Asked Questions

What was ARIDIS PHARMACEUTICAL INC's total assets in fiscal year 2022?

ARIDIS PHARMACEUTICAL INC closed fiscal year 2022 with $14.7M in total assets, $38.9M in total liabilities and -$24.2M in shareholder equity.

How fast is ARIDIS PHARMACEUTICAL INC's total assets growing?

ARIDIS PHARMACEUTICAL INC (ARDS) total assets fell by 45.2% year over year, from $26.8M to $14.7M in fiscal year 2022.

How has ARIDIS PHARMACEUTICAL INC's total assets changed over the years?

Across the 6 fiscal years this page covers, ARIDIS PHARMACEUTICAL INC (ARDS) total assets went from $26.5M in fiscal year 2017 to $14.7M in fiscal year 2022.

ARIDIS PHARMACEUTICAL INC (ARDS) reported $6.5M in total assets in Q3 2023. This represents a decrease of 46.1% from the same quarter a year earlier.

Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what ARIDIS PHARMACEUTICAL INC (ARDS) reported on that line in every period on record.